Patents by Inventor Ibrahim Abdou

Ibrahim Abdou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10941128
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: March 9, 2021
    Assignee: United Arab Emirates University
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Patent number: 10927088
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: February 23, 2021
    Assignee: United Arab Emirates University
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Publication number: 20200031789
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Application
    Filed: October 10, 2019
    Publication date: January 30, 2020
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Publication number: 20200031788
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Application
    Filed: October 10, 2019
    Publication date: January 30, 2020
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Publication number: 20200010413
    Abstract: The present invention benzoquinone derivatives of the formula (I): and to pharmaceutically acceptable salts or solvates thereof. In formula (I) one of X or Y is hydrogen and the other one of X or Y is 3-Trifluoro-methylaniline; 3,4,5-trifluoroaniline; 4-methoxylaniline; 4-fluoroaniline; 3,3?-Dimethyl-1,1?-Biphenyl-4,4?-diamine; 2-(pyrrolidin-1-yl)ethyl)amine; 4-trifluoromethyl-benzylamine; 4-fluorobenzyl-amine; 3,4-dimethoxybenzylamine; or 3,5-ditrifluoromethyl-benzylamine. Compounds of formula (I) have been identified as being useful in the treatment of cancer, in particular lung, breast and pancreatic cancer. The invention relates also to a method of making the benzoquinone derivatives and to methods of treatment.
    Type: Application
    Filed: September 24, 2019
    Publication date: January 9, 2020
    Inventors: Alaa Eldin Salem, Ibrahim Abdou, Ismail El Haty
  • Patent number: 10501428
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Grant
    Filed: August 9, 2014
    Date of Patent: December 10, 2019
    Assignee: United Arab Emirates University
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Publication number: 20170334871
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Application
    Filed: August 9, 2014
    Publication date: November 23, 2017
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Publication number: 20170283366
    Abstract: The present invention benzoquinone derivatives of the formula (I): and to pharmaceutically acceptable salts or solvates thereof. In formula (I) one of X or Y is hydrogen and the other one of X or Y is 3-Trifluoro-methylaniline; 3,4,5-trifluoroaniline; 4-methoxylaniline; 4-fluoroaniline; 3,3?-Dimethyl-1,1?-Biphenyl-4,4?-diamine; 2-(pyrrolidin-l-yl)ethyl)amine; 4-trifluoromethyl-benzylamine ; 4-fluorobenzyl-amine; 3,4-dimethoxybenzylamine; or 3,5-ditrifluoromethyl-benzylamine. Compounds of formula (I) have been identified as being useful in the treatment of cancer, in particular lung, breast and pancreatic cancer. The invention relates also to a method of making the benzoquinone derivatives and to methods of treatment.
    Type: Application
    Filed: April 4, 2016
    Publication date: October 5, 2017
    Inventors: Alaa Eldin Salem, Ibrahim Abdou, Ismail El Haty